Since 2007 the major changes in pharmaceutical pricing and reimbursement in all major EU countries have led to a large increase in the number of studies requiring the involvement of senior budget holders, referred to as payers.

Medicys has developed and outstanding network of what is, undeniably, the smallest and most difficult target group in the pharmaceutical arena.

Our access to local, regional, and national payers in each of France, Germany, Italy, Spain and the UK is unparalleled.

Medicys is extremely proud to be a preferred partner to the World’s two leading pricing and market access companies.

Conducting research with the above respondents is extremely difficult and communication between Medicys and its clients is absolutely key, to the extent that the usual screener is typically not used for such projects. Instead, Medicys will liaise with the client to understand the exact objectives, select the right candidate AND submit a bio of the respondent for approval before appointment confirmation.

Identifying and having access to the right respondents is only half the battle; one also needs the very best moderators who understand their market, policies and structures. This is why we have created a team of specialist bilingual moderators whose main focus is P&MA.

Depending on the topic of the research conducted we have access to senior stakeholders in all of the following:

Please click on the maps to see which HTA we have access to.

France	Germany	Italy	Spain	United Kingdom

To see examples of our recent Pricing & Market Access projects, click the link below:

Recent Projects